Narcolepsia con y sin cataplejia: una enfermedad rara, limitante e infradiagnosticada

Anales de Pediatría - Tập 71 - Trang 524-534 - 2009
M. Merino-Andréu1,2, A. Martínez-Bermejo1,3
1Unidad Pediátrica de Trastornos de Sueño, Hospital Universitario La Paz, Madrid, España
2Servicio de Neurofisiología Clínica, Hospital Universitario La Paz, Madrid, España
3Servicio de Neurología Infantil, Hospital Universitario La Paz, Madrid, España

Tài liệu tham khảo

Mignot, 1998, Genetic and familial aspects of narcolepsy, Neurology, 50, S16, 10.1212/WNL.50.2_Suppl_1.S16 American Academy of Sleep Medicine. International Classification of sleep Disorders. 2nd ed. Diagnostic and coding manual. Westchester: American Academy of Sleep Medicine; 2005. Nevsimalova, 2007, REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy, Sleep Med, 8, 784, 10.1016/j.sleep.2006.11.018 Vandeputte M, De Weerd A. Sleep disorders and depressive feelings: A global survey with the Beck depression scale. Sleep Medicine. 2003;4:343–345. Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009;41:708–11 Nishino, 2000, Narcolepsy: Genetic predisposition and neuropharmacological mechanisms. Review article, Sleep Med Rev, 4, 57, 10.1053/smrv.1999.0069 Nishino, 2000, Hypocretin (orexin) deficiency in human narcolepsy, Lancet, 355, 39, 10.1016/S0140-6736(99)05582-8 Mignot, 2002, The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias, Arch Neurol, 59, 1553, 10.1001/archneur.59.10.1553 Arii, 2004, CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders, Neurology, 63, 2440, 10.1212/01.WNL.0000147328.15956.B4 Tanaka, 2006, Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: Anti-Hcrt system antibody in narcolepsy, Sleep, 29, 633, 10.1093/sleep/29.5.633 Domínguez-Ortega, 2003, Narcolepsy-like symptoms in a patient with down syndrome and without obstructive sleep apnea, Sleep, 26, 285, 10.1093/sleep/26.3.285 Nishino, 2005, Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system, Sleep Med Rev, 9, 269, 10.1016/j.smrv.2005.03.004 Aldrich, 1989, Narcolepsy associated with lesions of the diencephalon, Neurology, 39, 1505, 10.1212/WNL.39.11.1505 Smit, 2006, Cataplexy leading to the diagnosis of Niemann-Pick disease type C, Pediatr Neurol, 35, 82, 10.1016/j.pediatrneurol.2005.12.012 Yoss, 1960, Narcolepsy in children, Pediatrics, 25, 1025 Navelet, 1976, Narcolepsy in children, 171 Young, 1988, Narcolepsy in a pediatric population, Am J Dis Child, 142, 210 Kotagal, 1990, Characteristics of narcolepsy in preteenaged children, Pediatrics, 85, 205, 10.1542/peds.85.2.205 Brown, 1995, Narcolepsy, Kleine-Levin syndrome, and other causes of sleepiness in children, 125 Kotagal, 1996, Narcolepsy in children, Semin Pediatr Neurol, 3, 36, 10.1016/S1071-9091(96)80027-1 Guilleminault, 1998, Narcolepsy in prepubertal children, Ann Neurol, 43, 135, 10.1002/ana.410430125 Wise, 2001, Narcolepsy in children, Semin Pediatr Neurol, 8, 198, 10.1053/spen.2001.29475 Hood, 2004, Narcolepsy: Diagnosis and management in early childhood, Journal Ped Neurol, 2, 65 Stores, 2006, The protean manifestations of childhood narcolepsy and their misinterpretation, Dev Med Child Neurol, 48, 307, 10.1017/S0012162206000661 Peterson, 2008, Pediatric narcolepsy, Brain Dev, 30, 609, 10.1016/j.braindev.2008.02.004 Vendrame, 2008, Narcolepsy in children: A single-center clinical experience, Pediatr Neurol, 38, 314, 10.1016/j.pediatrneurol.2007.12.010 Lenti, 1998, Narcolepsy in an 8-year-old boy: Neurologic and psychiatric study, J Child Neurol, 13, 405, 10.1177/088307389801300809 Serra, 2008, Cataplexy features in childhood narcolepsy, Mov Disord, 23, 858, 10.1002/mds.21965 Kok, 2002, Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans, J Clin Endocrinol Metab, 87, 805, 10.1210/jcem.87.2.8246 Plazzi, 2006, Narcolepsy-cataplexy associated with precocious puberty, Neurology, 66, 1577, 10.1212/01.wnl.0000216142.21375.71 Dahl, 1994, A clinic picture of child and adolescent narcolepsy, J Am Acad Child Adolesc Psychiatry, 33, 834, 10.1097/00004583-199407000-00009 Rubio, 2005, Métodos de evaluación de la excesiva somnolencia diurna, Vigilia-Sueño, 15, 118 Kothare, 2008, Narcolepsy and other hypersomnias in children, Curr Opin Pediatr, 20, 666, 10.1097/MOP.0b013e328316bd85 Hood, 2002, Paediatric narcolepsy: Complexities of diagnosis, J Paediatr Child Health, 38, 618, 10.1046/j.1440-1754.2002.00073.x Carskadon, 1986, Guidelines for the Multiple Sleep Latency Test (MSLT), a standard measure of sleepiness, Sleep, 9, 519, 10.1093/sleep/9.4.519 Littner, 2005, Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test, Sleep, 28, 113, 10.1093/sleep/28.1.113 Dauvilliers, 2004, Effect of age on MSLT results in patients with narcolepsy-cataplexy, Neurology, 62, 46, 10.1212/01.WNL.0000101725.34089.1E Kothare, 2008, The clinical and laboratory assessment of the sleepy child, Semin Pediatr Neurol, 15, 61, 10.1016/j.spen.2008.03.003 Kanbayashi, 2002, Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: Infants to elderly persons, Sleep, 25, 337, 10.1093/sleep/25.3.337 Dauvilliers, 2003, CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions, J Neurol Neurosurg Psychiatry, 74, 1667, 10.1136/jnnp.74.12.1667 Poryazova, 2007, Voxel-based morphometry and magnetic resonance spectroscopy in hypothalamus of narcolepsy patients, Sleep, 30 Derry, 2006, Increased serotonin receptor availability in human sleep: Evidence from an [18F]MPPF PET study in narcolepsy, Neuroimage, 30, 341, 10.1016/j.neuroimage.2005.09.052 Maquet, 1997, Positron emission tomography studies of sleep and sleep disorders, J Neurol, 244, S23, 10.1007/BF03160568 Stores, 2006, The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin, Pediatrics, 118, e1116, 10.1542/peds.2006-0647 Husain, 2004, Diet therapy for narcolepsy, Neurology, 62, 2300, 10.1212/WNL.62.12.2300 Greenhill, 2002, American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults, J Am Acad Child Adolesc Psychiatry, 41, 26S, 10.1097/00004583-200202001-00003 Murali, 2006, Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate, Sleep, 29, 1025, 10.1093/sleep/29.8.1025 Ivanenko, 2003, Modafinil in the treatment of excessive daytime sleepiness in children, Sleep Med, 4, 579, 10.1016/S1389-9457(03)00162-X Mignot, 2004, An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy, Leep Med Rev, 8, 333 Black, 2006, Sodium oxybate improves excessive daytime sleepiness in narcolepsy, Sleep, 29, 939, 10.1093/sleep/29.7.939 Billiard, 2006, EFNS guidelines on management of narcolepsy, Eur J Neurol, 13, 1035, 10.1111/j.1468-1331.2006.01473.x Morgenthaler, 2007, Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Standards of Practice Committee of the American Academy of Sleep Medicine, Sleep, 30, 1705, 10.1093/sleep/30.12.1705 2005, A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy, J Clin Sleep Med, 1, 391, 10.5664/jcsm.26368 2005, Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: A double-blind, placebo-controlled study in 228 patients, Sleep Med, 6, 415, 10.1016/j.sleep.2005.03.010 2002, A randomized, double-blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy, Sleep, 25, 42 2003, A 12-month, open-label, multicenter extension of orally administered sodium oxybate for the treatment of narcolepsy, Sleep, 26, 31 2003, The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms, J Toxicol Clin Toxicol, 41, 131, 10.1081/CLT-120019128 2004, Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy, Sleep Med, 5, 119, 10.1016/j.sleep.2003.11.002 Vendrame, 2008, Narcolepsy in children: A single-center clinical experience, Pediatr Neurol, 38, 314, 10.1016/j.pediatrneurol.2007.12.010 Dauvilliers, 2006, Follow-up of four narcolepsy patients treated with intravenous immunoglobulins, Ann Neurol, 60, ;153, 10.1002/ana.20892 Lecendreux, 2003, Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy, J Sleep Res, 12, 347, 10.1046/j.1365-2869.2003.00380.x Valko, 2008, No persistent effect of intravenous immunoglobulins in patients with narcolepsy and cataplexy, J Neurol, 10.1007/s00415-008-0996-2 González Luque JC, Álvarez-Mon M, coordinadores. Manual sobre aspectos médicos relacionados con la capacidad de conducción de vehículos. Madrid: Ed. DGT; 2001 Mignot, 2005, Emerging therapies in narcolepsy-cataplexy, Sleep, 28, 754, 10.1093/sleep/28.6.754